• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dawn Holcombe Addresses the Continuing Challenges of Defining Evidence and Value in Oncology

Article

Dawn Holcombe, President of DGH Consulting and Executive Director of the Connecticut Oncology Association, discusses how the increasing demand for data and defining evidence and value are so complex that collaboration between payers and providers is critical.

She also addresses her concern for the viability of the oncology market given the uncertainties of additional changes the federal government may make—especially in an election year—and how such changes could negatively impact the delivery of cancer care.

Related Videos
Manjool Shah, MD
Donna Culton, MD
Margaret Krackeler, MD
Philip Mease, MD
Jerry Shapiro, MD
Paul Nghiem, MD, PhD
Lawrence Eichenfield, MD
Daniel Siegel, MD
James Song, MD
A new study finds law enforcement presence in emergency departments may disrupt care. Lead author Prashasti Bhatnagar discusses policy and training solutions.
Related Content
Flat Medicare Advantage payments in 2027 may push higher costs and fewer benefits onto seniors despite CMS reforms. | Image Credit: Postmodern Studio - stock.adobe.com.jpeg

CMS Proposes Nearly Flat 2027 Medicare Advantage Payment Rates

January 27th 2026
Article

CMS’s 2027 proposed MA payment rate increase of .09% falls short of expectations, potentially increasing premiums and reducing benefits for seniors.

Read More

managed care cast logo

Reflecting on 15 Years of Health IT Evolution and What’s Next: Nate C. Apathy, PhD

January 27th 2026
Podcast

Nate C. Apathy, PhD, guest editor of AJMC's 15th Health IT special issue, calls for tools to be closely aligned with user needs.

Listen

Young man holding blue ribbon | Image Credit: Jo Panuwat D - stock.adobe.com

CRC Becomes Leading Cause of Cancer-Related Death in Younger Adults, Highlighting Prevention Gaps

January 26th 2026
Article

Experts underscored that educating clinicians and the public about red flag CRC symptoms could facilitate earlier screening, diagnosis, and treatment.

Read More

Transparency in Coverage Data to Expose Ghost Rates and Hold Payers Accountable: David Muhlestein, PhD

Transparency in Coverage Data to Expose Ghost Rates and Hold Payers Accountable: David Muhlestein, PhD

January 20th 2026
Podcast

David Muhlestein, PhD, breaks down ghost rates, data gaps, and why stronger oversight is needed to make Transparency in Coverage files usable for patients.

Listen

Doctor conducting liquid biopsy | Image Credit: syhin_stas - stock.adobe.com

ctDNA Positivity Associated With Worse Survival, Higher Recurrence Risk in Patients With NSCLC

January 25th 2026
Article

These findings support the potential role of ctDNA in prognostic assessment and early intervention.

Read More

Roberto Mina, MD, Winship Cancer Institute of Emory University

Teclistamab Transforms Early Myeloma Care: Roberto Mina, MD

January 23rd 2026
Article

The results of the phase 3 MajesTEC-9 trial showcase teclistamab's efficacy for patients with relapsed/refractory multiple myeloma, explained Roberto Mina, MD.

Read More

© 2026 MJH Life Sciences
AJMC®
All rights reserved.